Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BioCryst Pharmaceuticals, Inc.
(NQ:
BCRX
)
1.695
USD
-0.015 (-0.88%)
Streaming Delayed Price
/ Updated:
10:58 AM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about BioCryst Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
Next >
The Boston Chapter of the National Investor Relations Institute Announces its Board of Directors
August 18, 2009
from
Business Wire News Releases
BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
July 30, 2009
from
PR Newswire
BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
July 28, 2009
from
PR Newswire
BullMarket.com Updates Outlook on Swine Flu Stocks
July 24, 2009
from
PR Newswire
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
July 17, 2009
from
PR Newswire
StreetInvesting.com Free Research on PFCB, LOGI, BCRX, PSYS, LULU and CVLT
July 06, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by StreetInvesting.com (SI).
Read More
from
Marketwired News Releases
BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
May 14, 2009
from
PR Newswire
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
May 08, 2009
from
PR Newswire
BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
May 07, 2009
from
PR Newswire
WallStSense.com Free Research Report for Shareholders of BCRX, AVII, ATLS and ONXX
April 29, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com
Read More
from
Marketwired News Releases
Tickerspy.com Announces New Stock Index Tracking Companies Seeking Treatments and Vaccines for Swine Flu and Avian Flu
April 28, 2009
from
PR Newswire
Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
February 23, 2009
from
PR Newswire
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
February 06, 2009
from
PR Newswire
BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
February 02, 2009
from
PR Newswire
BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
January 30, 2009
from
PR Newswire
BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
January 08, 2009
from
PR Newswire
BioCryst Pharmaceuticals Elects Stanley C. Erck to its Board of Directors
December 23, 2008
from
PR Newswire
BioCryst Pharmaceuticals Continues Forodesine HCl Program in Chronic Lymphocytic Leukemia
December 22, 2008
from
PR Newswire
BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
December 05, 2008
from
PR Newswire
BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
November 03, 2008
from
PR Newswire
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
October 31, 2008
from
PR Newswire
BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
October 28, 2008
from
PR Newswire
BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
October 27, 2008
from
PR Newswire
BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
October 24, 2008
from
PR Newswire
Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
October 20, 2008
from
PR Newswire
BioCryst to Present at the JMP Healthcare Focus Conference
October 01, 2008
from
PR Newswire
BioCryst to Present at UBS 2008 Global Life Sciences Conference
September 16, 2008
from
PR Newswire
BioCryst Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
September 04, 2008
from
PR Newswire
BioCryst Reports Second Quarter 2008 Financial Results and Provides Corporate Update
August 07, 2008
from
PR Newswire
BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
July 31, 2008
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here